A Double-blinded, Parallel-group, Randomized, Active-controlled Phase 2 Clinical Trial to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intravenous HY-001 Versus Standard Colistin Methanesulfonate Sodium Monotherapy in Patients with Complicated Urinary Tract Infection (with or without pyelonephritis) or Acute Uncomplicated Pyelonephritis at Risk for Infection with Multidrug Resistant Gram-negative Pathogens.
100 项与 Helperby Therapeutics Ireland Ltd. 相关的临床结果
0 项与 Helperby Therapeutics Ireland Ltd. 相关的专利（医药）
100 项与 Helperby Therapeutics Ireland Ltd. 相关的药物交易
100 项与 Helperby Therapeutics Ireland Ltd. 相关的转化医学
